Genetron Health Announces Completion of Going Private Transa

BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular

Related Keywords

Cayman Islands , Beijing , China , United States , New York , Hong Kong , American , King Wood Mallesons , Genetron Holdings , Genetron New Co Limited Merger Sub , Genetron Holding Limited Parent , Davis Polk Wardwell , Exchange Commission , Meagher Flom , Company Nasdaq , Board The Special Committee , Genetron Holdings Limited Health , Genetron Health , Nasdaq , Securities Exchange , Holdings Limited , Genetron New Co Limited , New Genetron Holding Limited , Merger Agreement , Excluded Shares , Dissenting Shares , Share Merger , Effective Time , Per Share Merger Consideration , Merger Consideration , Deposit Agreement , New York Mellon , Nasdaq Global Market , Securities Exchange Act , Phelps Opinions Practice , Davis Polk , Special Committee , Wood Mallesons , Securities Litigation Reform Act ,